» Articles » PMID: 22960626

Animal Models of Parkinson's Disease: Vertebrate Genetics

Overview
Specialty General Medicine
Date 2012 Sep 11
PMID 22960626
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Parkinson's disease (PD) is a complex genetic disorder that is associated with environmental risk factors and aging. Vertebrate genetic models, especially mice, have aided the study of autosomal-dominant and autosomal-recessive PD. Mice are capable of showing a broad range of phenotypes and, coupled with their conserved genetic and anatomical structures, provide unparalleled molecular and pathological tools to model human disease. These models used in combination with aging and PD-associated toxins have expanded our understanding of PD pathogenesis. Attempts to refine PD animal models using conditional approaches have yielded in vivo nigrostriatal degeneration that is instructive in ordering pathogenic signaling and in developing therapeutic strategies to cure or halt the disease. Here, we provide an overview of the generation and characterization of transgenic and knockout mice used to study PD followed by a review of the molecular insights that have been gleaned from current PD mouse models. Finally, potential approaches to refine and improve current models are discussed.

Citing Articles

Preclinical studies and transcriptome analysis in a model of Parkinson's disease with dopaminergic ZNF746 expression.

Kim J, Yang S, Kim H, Vo D, Maeng H, Jo A Mol Neurodegener. 2025; 20(1):24.

PMID: 40022229 PMC: 11871723. DOI: 10.1186/s13024-025-00814-3.


Dual regulation of mitochondrial fusion by Parkin-PINK1 and OMA1.

Yamada T, Ikeda A, Murata D, Wang H, Zhang C, Khare P Nature. 2025; .

PMID: 39972141 DOI: 10.1038/s41586-025-08590-2.


Genetically modified non-human primate models for research on neurodegenerative diseases.

Pan M, Zhang H, Li X, Guo X Zool Res. 2024; 45(2):263-274.

PMID: 38287907 PMC: 11017080. DOI: 10.24272/j.issn.2095-8137.2023.197.


Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson's disease in rodent brains.

Berard M, Martinez-Drudis L, Sheta R, El-Agnaf O, Oueslati A Mol Neurodegener. 2023; 18(1):91.

PMID: 38012703 PMC: 10683293. DOI: 10.1186/s13024-023-00683-8.


Intranasal Exposure to Low-Dose Rotenone Induced Alpha-Synuclein Accumulation and Parkinson's Like Symptoms Without Loss of Dopaminergic Neurons.

Sharma M, Kaur J, Rakshe S, Sharma N, Khunt D, Khairnar A Neurotox Res. 2021; 40(1):215-229.

PMID: 34817799 DOI: 10.1007/s12640-021-00436-9.


References
1.
Lee M, Stirling W, Xu Y, Xu X, Qui D, Mandir A . Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc Natl Acad Sci U S A. 2002; 99(13):8968-73. PMC: 124407. DOI: 10.1073/pnas.132197599. View

2.
Gossen M, Bujard H . Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A. 1992; 89(12):5547-51. PMC: 49329. DOI: 10.1073/pnas.89.12.5547. View

3.
Gao L, Zhang J . Why are some human disease-associated mutations fixed in mice?. Trends Genet. 2003; 19(12):678-81. DOI: 10.1016/j.tig.2003.10.002. View

4.
Rosenthal N, Brown S . The mouse ascending: perspectives for human-disease models. Nat Cell Biol. 2007; 9(9):993-9. DOI: 10.1038/ncb437. View

5.
Dawson T, Ko H, Dawson V . Genetic animal models of Parkinson's disease. Neuron. 2010; 66(5):646-61. PMC: 2917798. DOI: 10.1016/j.neuron.2010.04.034. View